Recombinant proteins
Bulgaria Extends Insulin Export Ban for Another Month to Secure Domestic Supply
Bulgaria's Acting Minister of Health, Galya Kondeva, has issued a new order extending the ban on the export of insulin and other medications used to lower blood sugar, according to the Ministry of Health.
Bulgaria's Health Minister Downplays Medicine Shortage Concerns Amid Insulin Supply Issues
In today's briefing held at the Ministry of Health, Bulgaria's Minister of Health, Prof. Hristo Hinkov, addressed concerns regarding the shortage of certain medicines in the country, particularly insulin. Prof. Hinkov asserted that the perceived shortages and associated drama are exaggerated, emphasizing that the ministry diligently monitors the pharmaceutical market.
Bulgaria Implements Emergency Ban on Insulin and Child Antibiotic Exports
Bulgaria's Minister of Health, Prof. Hristo Hinkov, has issued a crucial order prohibiting the export of essential medications, encompassing insulin, blood sugar-lowering drugs, and antibiotics for children. The decision, effective from today, November 2, will remain in place until December 31, 2023, aiming to address the alarming shortage of life-saving medicines.
The Situation with the Availability of Antibiotics in Pharmacies in Bulgaria is Gradually Normalizing
The situation with the availability of antibiotics in pharmacies is gradually normalizing. A large number of the missing drugs were found in bulk warehouses. This was reported to the Bulgarian National Radio by Nikolay Kostov from the Union of Pharmacy Owners. The problem remains with the lack of several types of insulin and other medications for people with diabetes.
The UN to Reduce the “Overly Expensive" Price of Insulin
The World Health Organization has announced a scheme to reduce the "overly expensive" price of insulin, BNR reported, citing the BBC. The UN agency wants pharmaceutical companies to produce generic versions of the insulin that it will then test.
Since its discovery in 1923, in America, the price of insulin has risen from $ 1 per vial to about $ 300.
Revolutionary insulin patch research may prove to be diabetics’ saving grace
US scientists and researchers claim they have been able to develop the first smart insulin patch, according to a PNAS review. The patch automatically releases the needed insulin dose according to the needs of the diabetic individual.